AminoX EAAs White Bark Raspberry Ingredients & Drug Interactions
by BSN
What is this page for?
First and foremost: checking AminoX EAAs White Bark Raspberry against your medications. The heart of this page is the interaction checker and the full interaction report — how this product’s ingredients may interact with prescription and over-the-counter medicines you may be taking.
Around that, we add a pharmacist’s high-level view of the product as a whole — what’s inside, the evidence for its stated use, how transparent the label is, and what safety data exists — so you can see the full picture in one place. It’s educational information from our licensed clinical databases and the clinical staff at HelloPharmacist — not medical advice — and we don’t sell or endorse products. Our editorial policy
AminoX EAAs White Bark Raspberry is a dietary supplement by BSN with 8 active ingredients. Its ingredients are commonly taken for replacing fluids and electrolytes, preventing dehydration during exercise or illness, treating low blood sodium (under medical care).Based on those ingredients, 610 medications have a known interaction with it, the most serious rated major. The ingredients most likely to interact are Tryptophan, Sodium, Phenylalanine. Use the checker below to test your specific medication, or read the full HelloPharmacist Interaction Report.
Check Your Meds Against AminoX EAAs White Bark Raspberry by BSN
Ask about any prescription or over-the-counter medication and we check it for interactions with AminoX EAAs White Bark Raspberry by BSN — and tell you which ingredient is responsible.
AI summaries are generated from our interaction database for education only — always confirm with your pharmacist. How we use AI
Ask the Pharmacist
A licensed pharmacist will answer your question by email — free, usually within 24 hours.
Got it — thank you!
A licensed pharmacist will answer within 24 hours. Keep an eye on your email (worth checking spam, just in case).
HelloPharmacist Scorecard of AminoX EAAs White Bark Raspberry by BSN
Our pharmacy team’s full take, with four database checks built into the cards below — a summary of what is known, not a grade of the product itself.
What’s inside
Full disclosure
This powder contains 10 active ingredients, all amino acids essential to your body. Sodium provides electrolyte support.
The core amino acids are leucine, isoleucine, and valine (the three branched-chain amino acids or BCAAs, supplied in a 2:1:1 blend), plus histidine, methionine, phenylalanine, threonine, tryptophan, and L-lysine. These are proteins' building blocks — your body uses them for muscle repair, neurotransmitter production, and dozens of other functions.
The inactive ingredients are flavoring, acids (malic and citric), sweeteners (sucralose and acesulfame potassium), and anti-caking agents (silicon dioxide and calcium silicate), plus colorant (Blue 1).
Does it work?
Not established
The evidence for effectiveness varies by ingredient and purpose. Sodium is Likely Effective for cystic fibrosis and Possibly Effective for amphotericin B nephrotoxicity (kidney damage from that antibiotic), but we hold insufficient evidence for its use in congestive heart failure or bipolar disorder.
Histidine is Possibly Effective for cholera but has insufficient evidence for eczema, kidney failure, or rheumatoid arthritis. Methionine is Possibly Effective for neural tube birth defects but insufficient evidence for hay fever, asthma, and other conditions.
Phenylalanine is Possibly Effective for vitiligo but Possibly Ineffective for ADHD and has insufficient evidence for alcohol use disorder and multiple sclerosis. Threonine is Possibly Ineffective for ALS and has insufficient evidence for multiple sclerosis and spasticity.
L-tryptophan is Possibly Ineffective for depression and has insufficient evidence for anxiety, athletic performance, and premenstrual dysphoric disorder. L-lysine is Possibly Effective for cold sores but has insufficient evidence for child growth, pressure ulcers, and diabetic foot ulcers.
For leucine, isoleucine, valine, and the blend ingredients, we hold no effectiveness ratings.
How safe is it?
Well-documented data
Sodium is well tolerated at normal dietary amounts but carries caution: too much is linked to high blood pressure and heart strain, and you should avoid sodium supplements or very high intake without medical advice. Histidine is Likely Safe in food amounts but supplement safety at higher doses is not well established.
Methionine is Likely Safe in food amounts and generally well tolerated in oral doses, though high-dose supplements may cause dizziness, drowsiness, low blood pressure (hypotension), irritability, and vomiting. Phenylalanine is generally tolerated in food but supplements should be avoided — avoid them entirely if you have PKU (phenylketonuria).
Threonine from food is safe; headache and minor gastrointestinal upset (diarrhea, gas, constipation) have been reported with supplements. L-tryptophan is generally well tolerated but may cause belching, diarrhea, drowsiness, dry mouth, gas, headache, lightheadedness, nausea, stomach pain, blurred vision, and vomiting.
Rare serious adverse effect: in 1989, a contaminated batch caused eosinophilia-myalgia syndrome (a neurological disorder); almost all cases came from one Japanese manufacturer and L-tryptophan was recalled in the US in 1990. L-lysine is generally well tolerated at typical doses but high amounts may cause stomach upset, abdominal pain, diarrhea, and indigestion.
Meds to double-check
Major interaction found
Check these medication types before you start: levodopa (Major), CNS depressants like sedatives and strong pain relievers (Major), NMDA antagonists like memantine (Major), blood pressure medications (Moderate), lithium (Moderate), serotonergic drugs such as certain antidepressants (Moderate), corticosteroids (Moderate), baclofen (Moderate), non-selective MAOIs (Moderate), and 5-HT4 agonists (Minor). Use the medication checker on this page for your specific drugs.
The bottom line
Scorecard at a glanceFully disclosed formula with no established evidence rating for its marketed use. Major medication interactions have been identified, and safety information is well characterized.
This amino acid powder is aimed at muscle support and recovery. If you take levodopa (Parkinson disease), CNS depressants, serotonergic drugs, lithium, blood pressure medications, NMDA antagonists, baclofen, or older antidepressants (MAOIs), check your exact medications below before starting.
People with PKU should not take phenylalanine. If you're pregnant, breastfeeding, or have kidney or heart disease, talk with your pharmacist first.
Educational only — not medical advice; always confirm with your pharmacist. Our editorial policy · How we use AI
Assessment coverage: 7 of 10 active ingredients matched to our full ingredient reviews (monographs). Based on the product label dated Jan 23, 2023.
This Scorecard evaluates available label information, ingredient evidence, and known medication-safety considerations. It does not independently verify product identity, purity, potency, contamination, or manufacturing quality. How these ratings are computed
General information
Key facts about AminoX EAAs White Bark Raspberry, straight from the product label.
| Brand | BSN |
|---|---|
| Barcode (UPC) | 834266010837 |
| Net contents | 13.2 Ounce(s); 375 Gram(s) |
| Market status | On market |
| Date entered into DSLD | Jan 23, 2023 |
| DSLD ID | 278646 |
| Product type | Amino Acid/protein |
| Supplement form | Powder |
| Dietary claims / uses | All Other, Structure/Function |
| Intended target group(s) | Adult (18 - 50 Years), Women (not pregnant or lactating), Sugar Free |
Everything in this section is reproduced from the manufacturer’s own product label — it’s the label speaking, not HelloPharmacist. We show it so you can see exactly what the maker states; we don’t verify or endorse those statements.
Supplement Facts
The label details for AminoX EAAs White Bark Raspberry by BSN, sourced from the NIH Dietary Supplement Label Database.
Supplement Facts
| Ingredient | Amount | % DV |
|---|---|---|
| Calories | 5 Calorie(s) | -- |
| Total Carbohydrates | 1 Gram(s) | 1% |
| Sodium | 5 mg | 1% |
| Total Sugars | 0 Gram(s) | -- |
| added Sugars | 0 Gram(s) | -- |
| Leucine | 2500 mg | -- |
| Histidine | 400 mg | -- |
| Isoleucine | 1250 mg | -- |
| Methionine | 400 mg | -- |
| Phenylalanine | 600 mg | -- |
| Threonine | 1400 mg | -- |
| Valine | 1250 mg | -- |
| Essential Amino Acids | 0 NP | -- |
| Tryptophan | 400 mg | -- |
| BCAA 2:1:1 Blend | 0 NP | -- |
| L-Lysine | 1800 mg | -- |
Other ingredients: Natural and Artifcial Flavors, Malic Acid, Citric Acid, Sucralose, Silicon Dioxide, Calcium Silicate, Acesulfame Potassium, Blue 1
Tap any ingredient to jump to its full detail below.
These statements are the manufacturer’s wording, reproduced from the product label — the label is saying it, not HelloPharmacist. We don’t verify or endorse them.
Formula
Muscle protein synthesis is what everyone is after, and protein synthesis demands the essential amino acids that your body doesn't produce on its own. Muscle protein synthesis is unlocked when you have all 9 essential amino acids. That's why the PhD-accredited scientists on the BSN research team dialed up AMINOx EAAs with a 10 gram serving of all 9 EAAs, giving your muscles even more of what they need. Plus, AMINOx EAAs is available in a variety of exciting flavors. When your goals are performance and recovery, go with AMINOx EAAs.
10g essential amino acids 5g BCAAs (2:1:1)
10g essential amino acids per serving
White Bark Raspberry Artificially flavored
Formulation
May help spare muscle during prolonged or endurance exercise
The result is a precision engineered formula for muscle protein synthesis, recovery and endurance - all with zero caffeine, and zero sugar.
Muscle protein synthesis, recovery and endurance
Non-caffeinated
Your muscle support & recovery is essential
Zero sugar
This product has been manufactured by a Good Manufacturing Practices (GMP) facility.
Precautions
Warning: Consult your physician before using this product if you are taking any medications or are under a physician's care for a medical condition. Not for use by those under the age of 18 or women who are pregnant, trying to get pregnant, or are nursing.
Not for use by those under the age of 18 or women who are pregnant, trying to get pregnant, or are nursing.
Suggested/Recommended/Usage/Directions
Directions: Mix 15g (about 1 scoop) with 10-12 fl oz of water or any beverage of your choice before, during, or after your workout. Suggested use: For healthy adults, consume as part of a balanced diet and exercise program.
Storage
Store in a cool, dry place away from direct sunlight.
Contents sold by weight not volume. Some settling will occur.
FDA Disclaimer Statement
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
General Statements
For more updates follow @BSNsupplements Facebook, Instagram, Twitter
FDA Statement of Identity
Dietary Supplement
Seals/Symbols
Manufactured in the USA. This product contains ingredients of international and domestic origin.
Is this label outdated? Report a formula or label change and our pharmacy team will review it.
AminoX EAAs White Bark Raspberry by BSN label
The label scan from the NIH Dietary Supplement Label Database. Tap to enlarge.
Label images are published by the NIH Dietary Supplement Label Database for the version of this product on file. Always read your actual product label.
View the full label (PDF)The Ingredients in AminoX EAAs White Bark Raspberry by BSN
These are the 8 active ingredients this product is made of. Select any to open its full monograph.
Serving size15 Gram(s) Dosage formPowder Servings per container25 Amounts shown are per serving.
Most supplement products combine several ingredients, and a medication can interact with the product through any one of them. Each ingredient below shows whether it has known drug interactions.
Sodium
Interacts with205 drugs
Sodium is an essential mineral and electrolyte your body needs to balance fluids, support nerves, and help muscles work. Most people in modern diets g...
Sodium monograph & interactionsEssential Amino Acids
- › Histidine
- › Methionine
- › Phenylalanine
- › Threonine
- › Tryptophan
- › BCAA 2:1:1 Blend
- › L-Lysine
Other (inactive) ingredients: Natural and Artifcial Flavors, Malic Acid, Citric Acid, Sucralose, Silicon Dioxide, Calcium Silicate, Acesulfame Potassium, Blue 1. These complete the product’s ingredient list but are not active constituents.
AminoX EAAs White Bark Raspberry by BSN Drug Interactions
HelloPharmacist Interaction Report
AminoX EAAs White Bark Raspberry by BSN is a 10-ingredient amino acid powder with documented interactions affecting a substantial number of medications.
The most serious interaction involves phenylalanine and levodopa (used for Parkinson disease) — phenylalanine competes with levodopa for entry into the brain, which can worsen tremor, rigidity, and symptom control. This is a Major-severity interaction.
Read the full breakdown — every affected drug type, severity by severity
Sodium in this product has Moderate interactions with blood pressure medications (antihypertensives), lithium, corticosteroids, and several other drugs. High sodium intake can reduce how well blood pressure drugs work and can dangerously raise lithium levels in your blood.
Tryptophan carries Major-severity risk with CNS depressants (sedatives, sleep aids, pain relievers that cause drowsiness) due to additive sedation, and Moderate risk with serotonergic drugs (certain antidepressants, migraine medications) because of the risk of serotonin syndrome. Threonine has a Major interaction with NMDA antagonists (memantine, ketamine, dextromethorphan).
Phenylalanine also interacts with baclofen (muscle relaxant) and non-selective MAOIs (older antidepressants) at Moderate severity. L-lysine carries a Minor interaction with 5-HT4 agonists (prucalopride, mosapride).
Histidine, methionine, and leucine, isoleucine, and valine (which are part of the BCAA blend) have been checked for interactions and show no interactions documented in our data — though this is not a guarantee none exist. Essential Amino Acids and BCAA 2:1:1 Blend are labeled as blends, so their components are already listed individually above.
Run your exact medications through the tool on this page before starting.
Check your own medications below · Editorial policy · How we use AI
Want to check YOUR meds against AminoX EAAs White Bark Raspberry?
Ask about interactions with your drugs in plain English — “Can I take it with lisinopril?” — and we find you the answer in seconds, ingredient by ingredient.
Go to the checkerIngredients driving the most interactions
Individual Drug Interactions
The ingredients in AminoX EAAs White Bark Raspberry interact with 610 drugs. Click any drug to see the details.
5 of the 8 ingredients in AminoX EAAs White Bark Raspberry interact with drugs. Each result below shows which ingredient is responsible. Tryptophan Sodium Phenylalanine Threonine L-Lysine
PentobarbitonePentobarbitone
How Pentobarbitone interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Pentobarbitone interactionPerampanelFycompa
How Perampanel interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Perampanel interactionPhenacemidePhenurone
How Phenacemide interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Phenacemide interactionPhenelzine SulfateNardil
How Phenelzine Sulfate interacts with AminoX EAAs White Bark Raspberry — through 2 ingredients. Tap an ingredient for the detail:
TryptophanCns Depressants, Serotonergic Drugs Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Phenelzine Sulfate interactionPhenylalanineMonoamine Oxidase Inhibitors (maois) Moderate
Interaction Summary
Theoretically, concomitant use of L-phenylalanine and non-selective MAOIs might increase the risk of hypertensive crisis.
Read the full Phenylalanine + Phenelzine Sulfate interactionPhenobarbitalLuminal, Phenobarbital, Solfoton
How Phenobarbital interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Phenobarbital interactionPhenobarbital, PhenytoinDilantin with PB
How Phenobarbital, Phenytoin interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Phenobarbital, Phenytoin interactionPhenobarbital, Sodium NitrateSoniphen
How Phenobarbital, Sodium Nitrate interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Phenobarbital, Sodium Nitrate interactionPhensuximideMilontin
How Phensuximide interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Phensuximide interactionPhentermine, TopiramateQsymia
How Phentermine, Topiramate interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Phentermine, Topiramate interactionPhenytoinDi-Phen, Dilantin, Dilantin Infatabs, Dilantin injection, Dilantin Kapseals, Phenytek
How Phenytoin interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Phenytoin interactionPrazepamCentrax
How Prazepam interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Prazepam interactionPregabalinLyrica, Lyrica CR
How Pregabalin interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Pregabalin interactionPrimidoneMysoline
How Primidone interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Primidone interactionPropiomazineLargon
How Propiomazine interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Propiomazine interactionPropoxypheneDarvon, Davon, Margesic, Prophene-65
How Propoxyphene interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Propoxyphene interactionPropoxyphene NapsylateDarvon N
How Propoxyphene Napsylate interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Propoxyphene Napsylate interactionQuazepamDoral
How Quazepam interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Quazepam interactionRamelteonRozerem
How Ramelteon interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Ramelteon interactionRemifentanilUltiva
How Remifentanil interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Remifentanil interactionRemimazolam BesylateByfavo
How Remimazolam Besylate interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Remimazolam Besylate interactionRufinamideBanzel
How Rufinamide interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Rufinamide interactionSecobarbital SodiumSeconal
How Secobarbital Sodium interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Secobarbital Sodium interactionSodium ValproateEpilim
How Sodium Valproate interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanSerotonergic Drugs, Cns Depressants Major
Interaction Summary
Theoretically, combining L-tryptophan with serotonergic drugs might cause additive serotonergic effects.
Read the full Tryptophan + Sodium Valproate interactionSufentanil CitrateDsuvia
How Sufentanil Citrate interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Sufentanil Citrate interactionSuvorexantBelsomra
How Suvorexant interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Suvorexant interactionTasimelteonHetlioz, Hetlioz Lq
How Tasimelteon interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Tasimelteon interactionTemazepamApo-Temazepam, Dom-Temazepam, Gen-Temazepam, Novo-Temazepam, Restoril, Temazepam Gelthix
How Temazepam interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Temazepam interactionTiagabineGabitril
How Tiagabine interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Tiagabine interactionTopiramateEprontia, Qudexy XR, Topamax, Trokendi XR
How Topiramate interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanCns Depressants Major
Interaction Summary
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Read the full Tryptophan + Topiramate interactionTramadolQdolo, Ultram, Zytram XL
How Tramadol interacts with AminoX EAAs White Bark Raspberry — through 1 ingredient. Tap an ingredient for the detail:
TryptophanSerotonergic Drugs, Cns Depressants Major
Interaction Summary
Theoretically, combining L-tryptophan with serotonergic drugs might cause additive serotonergic effects.
Read the full Tryptophan + Tramadol interactionEach ingredient & the kinds of drugs it affects
For each ingredient in AminoX EAAs White Bark Raspberry with known interactions, here are the types of medications they can affect. Open any type for the detail — or search your exact drug in the checker above.
Tryptophan
Cns Depressants
Theoretically, concomitant use of L-tryptophan with CNS depressants might cause additive sedative effects.
Clinical research shows that L-tryptophan can cause fatigue and drowsiness.
Serotonergic Drugs
Theoretically, combining L-tryptophan with serotonergic drugs might cause additive serotonergic effects.
L-tryptophan is a precursor to serotonin. Theoretically, combining serotonergic drugs with L-tryptophan might increase the risk of serotonergic side effects, including serotonin syndrome and cerebral vasoconstrictive disorders.
Sodium
Antihypertensive Drugs
Theoretically, a high intake of dietary sodium might reduce the effectiveness of antihypertensive drugs.
High intake of dietary sodium can increase systolic and diastolic blood pressure. Also, high intake of sodium may necessitate increased use of antihypertensive medications to achieve blood pressure control in some patients, such as those with chronic kidney disease.
Corticosteroids
Concomitant use of mineralocorticoids and some glucocorticoids with sodium supplements might increase the risk of hypernatremia.
Mineralocorticoids and some glucocorticoids (corticosteroids) cause sodium retention. This effect is dose-related and depends on mineralocorticoid potency. It is most common with hydrocortisone, cortisone, and fludrocortisone, followed by prednisone and prednisolone.
Didanosine (Videx)
Concomitant use of didanosine with additional sodium from dietary or supplemental sources may increase the risk of hypernatremia.
Didanosine formulations contain a significant amount of sodium.
Lithium
Altering dietary intake of sodium might alter the levels and clinical effects of lithium.
High sodium intake can reduce plasma concentrations of lithium by increasing lithium excretion. Reducing sodium intake can significantly increase plasma concentrations of lithium and cause lithium toxicity in patients being treated with lithium carbonate. Stabilizing sodium intake is shown to reduce the percentage of patients with lithium level fluctuations above 0.8 mEq/L. Patients taking lithium should avoid significant alterations in their dietary intake of sodium.
Sodium Phosphates
Theoretically, concomitant use of sodium phosphate with sodium supplements might increase the risk of hypernatremia.
Use of high doses (> 45 mL in 24 hours) of sodium phosphate, such as those used for bowel cleansing before surgery, can lead to serious electrolyte disturbances, including hypernatremia. The risk of hypernatremia is highest in the elderly and people with other risk factors for electrolyte disturbances.
Sodium-Containing Drugs
Concomitant use of sodium-containing drugs with additional sodium from dietary or supplemental sources may increase the risk of hypernatremia and long-term sodium-related complications.
The Chronic Disease Risk Reduction (CDRR) intake level of 2.3 grams of sodium daily indicates the intake at which it is believed that chronic disease risk increases for the apparently healthy population. Some medications contain high quantities of sodium. When used in conjunction with sodium supplements or high-sodium diets, the CDRR may be exceeded. Additionally, concomitant use may increase the risk for hypernatremia; this risk is highest in the elderly and people with other risk factors for electrolyte disturbances.
Tolvaptan (Samsca)
Theoretically, concomitant use of tolvaptan with sodium might increase the risk of hypernatremia.
Tolvaptan is a vasopressin receptor 2 antagonist that is used to increase sodium levels in patients with hyponatremia. Patients taking tolvaptan should use caution with the use of sodium salts such as sodium chloride.
Phenylalanine
Levodopa
Phenylalanine, especially in high doses, can reduce the effectiveness of levodopa.
Phenylalanine competes with levodopa for carrier-mediated transport into the brain. The resulting reduction in levels of levodopa in the brain can exacerbate tremor, rigidity, and the "on-off" phenomenon in patients with Parkinson disease.
Baclofen
Concomitant intake of phenylalanine may reduce the intestinal absorption of baclofen.
Phenylalanine and baclofen share the same intestinal carrier for absorption; phenylalanine competitively inhibits the absorption of baclofen, reducing its plasma levels.
Monoamine Oxidase Inhibitors (Maois)
Theoretically, concomitant use of L-phenylalanine and non-selective MAOIs might increase the risk of hypertensive crisis.
L-phenylalanine is metabolized to tyrosine. Some evidence suggests that L-phenylalanine, given with the non-selective MAOI pargyline, might prevent the elimination of tyramine, increasing the risk of hypertensive crisis. However, this was not reported in a small number of patients when using L-phenylalanine with the partially selective MAO-B inhibitor, selegiline.
Threonine
Nmda Antagonists
Theoretically, threonine might decrease the effects of NMDA antagonists.
Threonine increases central nervous system (CNS) glycine levels. Glycine seems to bind a site on NMDA receptors and enhance the activity of the receptors.
L-Lysine
5-Ht4 Agonists
Theoretically, lysine may reduce the effects of 5-HT4 agonists.
Animal research suggests that L-lysine is a partial serotonin receptor 4 (5-HT4) antagonist and inhibits diarrhea induced by the 5-HT4 agonist, 5-hydroxytryptophane.
Brand information
Manufacturer and brand details for AminoX EAAs White Bark Raspberry, from the product label.
BSN
See all BSN products- Name
- Bio-Engineered Supplements & Nutrition, Inc.
- Street Address
- 3500 Lacey Road, Suite 1200
- City
- Downers Grove
- State
- IL
- ZipCode
- 60515
- Phone Number
- 877.673.3727
- Web Address
- www.goBSN.com
AminoX EAAs White Bark Raspberry by BSN: Common Questions
Does AminoX EAAs White Bark Raspberry by BSN interact with any medications?
How can one product interact with so many drugs?
Where does this information come from?
Is it safe to take this if I'm pregnant?
Can I take this while breastfeeding?
Does this contain phenylalanine, and is that a problem?
What does L-lysine do in this product?
Are there any fillers in this powder?
What if I feel drowsy or lightheaded after taking this?
Written and reviewed by the HelloPharmacist editorial staff. Our editorial policy
Not sure if AminoX EAAs White Bark Raspberry is safe with your meds?
Our pharmacists answer your medication & supplement questions — free.
Label information is sourced from the NIH Dietary Supplement Label Database and reflects the product version on file; always read your actual product label. This page is for education only and is not a substitute for professional medical advice. Confirm with your pharmacist or doctor before combining supplements and medications.
The Full Monographs Behind AminoX EAAs White Bark Raspberry’s Ingredients
Every ingredient we hold a full HelloPharmacist monograph for — uses, evidence, safety, and the complete interaction list.
Sodium
Interacts with 205 drugsSodium is an essential mineral and electrolyte your body needs to balance fluids, support nerves, and help muscles work. Most people in modern diets get more than enough—often too much—from...
Read the full Sodium monograph → Herb & supplement monographHistidine
Histidine is an essential amino acid your body needs to build proteins and to make compounds like histamine and carnosine. Most people get enough from a normal diet, and good-quality researc...
Read the full Histidine monograph → Herb & supplement monographMethionine
Methionine is an essential amino acid that your body needs for protein building and many basic chemical reactions. Most people get enough from a normal diet, and supplements are generally no...
Read the full Methionine monograph → Herb & supplement monographPhenylalanine
Interacts with 16 drugsPhenylalanine is an essential amino acid the body uses to make brain chemicals like dopamine and norepinephrine. Some people take it for mood, vitiligo, or pain, but the evidence is mostly l...
Read the full Phenylalanine monograph → Herb & supplement monographThreonine
Interacts with 3 drugsThreonine is an essential amino acid your body needs but cannot make, so you must get it from food or supplements. Most people get plenty from a normal diet, and high-quality evidence for ta...
Read the full Threonine monograph → Herb & supplement monographL-tryptophan
Interacts with 394 drugsL-tryptophan is an essential amino acid the body uses to make serotonin and melatonin, and people take it to support sleep and mood. The evidence for supplement use is limited and mixed, and...
Read the full L-tryptophan monograph → Herb & supplement monographLysine
Interacts with 1 drugLysine is an essential amino acid your body cannot make on its own, so it must come from food or supplements. People most often take extra lysine to try to prevent or shorten cold sores, but...
Read the full Lysine monograph →Sources & How We Checked
AminoX EAAs White Bark Raspberry's label data comes from the NIH Dietary Supplement Label Database; the ingredient interaction data is from the Natural Medicines database, reviewed by our pharmacists.
- NIH Dietary Supplement Label Database (DSLD) — The official product label on file for this supplement.
- Natural Medicines (Therapeutic Research Center) — Evidence-graded clinical reference behind the ingredient interaction data.
Content is written and reviewed by licensed HelloPharmacist pharmacists. See our data sources and editorial standards for how this information is built and checked.
The 105 references behind this product’s interaction data
Every citation that drives the interaction findings for this product’s ingredients, from the evidence-graded Natural Medicines (TRC Healthcare) database. Open an ingredient to browse its citations — links open the study on PubMed or the publisher’s site.
Sodium 38 references
- Garabedian-Ruffalo SM, Ruffalo RL. Drug and nutrient interactions. Am Fam Physician 1986;33:165-74.
- Food and Drug Administration Science Background: Safety of Sodium Phosphates Oral Solution. September 17, 2001. Available at: http://www.fda.gov/cder/drug/safety/sodiumphospate.htm
- Coton T, Mallaret C, Coilliot C, Carre D, Guisset M. Severe acute ulcerated gastritis induced by salt. Presse Med 2009;38(3):499-500. PubMed
- Frings-Meuthen P, Buehlmeier J, Baecker N, et al. High sodium chloride intake exacerbates immobilization-induced bone resorption and protein losses. J Appl Physiol 2011;111(2):537-542. PubMed
- Frings-Meuthen P, Baecker N, Heer M. Low-grade metabolic acidosis may be the cause of sodium chloride-induced exaggerated bone resorption. J Bone Miner Res 2008;23(4):517-524. PubMed
- Alam S, Johnson AG. A meta-analysis of randomised controlled trials (RCT) among healthy normotensive and essential hypertensive elderly patients to determine the effect of high salt (NaCl) diet of blood pressure. J Hum Hypertens 1999;13(6):367-74.
- Boudville N, Ward S, Benaroia M, House AA. Increased sodium intake correlates with greater use of antihypertensive agents by subjects with chronic kidney disease. Am J Hypertens 2005;18(10):1300-5. PubMed
- Bennett WM. Drug interactions and consequences of sodium restriction. Am J Clin Nutr 1997;65(2 Suppl):678S-681S. PubMed
- Okusa MD, Crystal LJ. Clinical manifestations and management of acute lithium intoxication. Am J Med 1994;97(4):383-9. PubMed
- Food and Nutrition Board, Institute of Medicine. Dietary reference intakes for water, potassium, sodium, chloride, and sulfate. Washington, DC: National Academy Press, 2005. Available at: http://www.nap.edu/openbook.php?record_id=10925. DOI
- D'Elia L, Rossi G, Ippolito R, Cappuccio FP, Strazzullo P. Habitual salt intake and risk of gastric cancer: a meta-analysis of prospective studies. Clin Nutr 2012;31(4):489-98. PubMed
- Goldsmith SR. Hyponatremia in heart failure: time for a trial. J Card Fail 2013;19(6):398-400. PubMed
- Willocks L, Brettle R, Keen J, Valentine C, Pinching AJ. Formulations of didanosine (ddI) and salt overload. Lancet 1992;339(8786):190.
- Chen L, Zhang Z, Chen W, Whelton PK, Appel LJ. Lower Sodium Intake and Risk of Headaches: Results From the Trial of Nonpharmacologic Interventions in the Elderly. Am J Public Health. 2016;106(7):1270-5. PubMed
- Cook NR, Appel LJ, Whelton PK. Lower levels of sodium intake and reduced cardiovascular risk. Circulation. 2014;129(9):981-9. PubMed
- Cook NR, Appel LJ, Whelton PK. Sodium Intake and All-Cause Mortality Over 20 Years in the Trials of Hypertension Prevention. J Am Coll Cardiol. 2016;68(15):1609-1617. PubMed
- Mente A, O'Donnell M, Rangarajan S, et al. Associations of urinary sodium excretion with cardiovascular events in individuals with and without hypertension: a pooled analysis of data from four studies. Lancet. 2016;388(10043):465-75. PubMed
- Moosavian SP, Haghighatdoost F, Surkan PJ, Azadbakht L. Salt and obesity: a systematic review and meta-analysis of observational studies. Int J Food Sci Nutr. 2017;68(3):265-277. PubMed
- O'Donnell M, Mente A, Rangarajan S, et al. Urinary sodium and potassium excretion, mortality, and cardiovascular events. N Engl J Med. 2014;371(7):612-23. DOI
- Poggio R, Gutierrez L, Matta MG, Elorriaga N, Irazola V, Rubinstein A. Daily sodium consumption and CVD mortality in the general population: systematic review and meta-analysis of prospective studies. Public Health Nutr. 2015;18(4):695-704. PubMed
- Stallings VA, Harrison M, Oria M; Committee to Review the Dietary Reference Intakes for Sodium and Potassium, Food and Nutrition Board, Health and Medicine Division, National Academies of Sciences, Engineering, and Medicine. Washington (DC): National Acad
- Mahtani KR, Heneghan C, Onakpoya I, et al. Reduced Salt Intake for Heart Failure: A Systematic Review. JAMA Intern Med. 2018 Dec 1;178(12):1693-1700. PubMed
- Yancy CW. Sodium Restriction in Heart Failure: Too Much Uncertainty-Do the Trials. JAMA Intern Med. 2018 Dec 1;178(12):1700-1701. PubMed
- He FJ, Campbell NRC, Ma Y, MacGregor GA, Cogswell ME, Cook NR. Errors in estimating usual sodium intake by the Kawasaki formula alter its relationship with mortality: implications for public health. Int J Epidemiol. 2018;47(6):1784-1795. PubMed
- Murthy K, Ondrey GJ, Malkani N, et al. THE EFFECTS OF HYPONATREMIA ON BONE DENSITY AND FRACTURES: A SYSTEMATIC REVIEW AND META-ANALYSIS. Endocr Pract. 2019;25(4):366-378. PubMed
- Messerli FH, Hofstetter L, Syrogiannouli L, et al. Sodium intake, life expectancy, and all-cause mortality. Eur Heart J 2021;42(21):2103-2112. PubMed
- Graudal NA, Hubeck-Graudal T, Jurgens G. Effects of low sodium diet versus high sodium diet on blood pressure, renin, aldosterone, catecholamines, cholesterol, and triglyceride. Cochrane Database Syst Rev 2020;12(12):CD004022. PubMed
- Giatti S, Santos RB, Aielo AN, et al. Association of sodium with obstructive sleep apnea. The ELSA-Brasil study. Ann Am Thorac Soc 2021;18(3):502-510. PubMed
- Nan X, Lu H, Wu J, et al. The interactive association between sodium intake, alcohol consumption and hypertension among elderly in northern China: a cross-sectional study. BMC Geriatr 2021;21(1):135. PubMed
- Kyozuka H, Fukusda T, Murata T, et al. Impact of preconception sodium intake on hypertensive disorders of pregnancy: The Japan Environment and Children's study. Pregnancy Hypertens 2021;23:66-72. PubMed
- Zhao L, Ogden CL, Yang Q, et al. Association of usual sodium intake with obesity among US children and adolescents, NHANES 2009-2016. Obesity (Silver Spring) 2021;29(3):587-594. PubMed
- Ma Y, He FJ, Sun Q, et al. 24-Hour urinary sodium and potassium excretion and cardiovascular risk. N Engl J Med 2022;386(3):252-263. PubMed
- Liu J, Yang X, Zhang P, et al. Association of urinary sodium excretion and left ventricular hypertrophy in people with type 2 diabetes mellitus: A cross-sectional study. Front Endocrinol (Lausanne) 2021;12:728493. PubMed
- Filippini T, Malavolti M, Whelton PK, Vinceti M. Sodium intake and risk of hypertension: A systematic review and dose-response meta-analysis of observational cohort studies. Curr Hypertens Rep 2022;24(5):133-144. PubMed
- Wang DD, Li Y, Nguyen XT, et al. Dietary sodium and potassium intake and risk of non-fatal cardiovascular diseases: The million veteran program. Nutrients 2022;14(5):1121. PubMed
- Kwak JH, Park CH, Eun CS, et al. The associations of dietary intake of high sodium and low zinc with gastric cancer mortality: A prospective cohort study in Korea. Nutr Cancer 2022;74(10):3501-3508. PubMed
- George S, Maiti R, Mishra BR, Jena M, Mohapatra D. Effect of regulated add-on sodium chloride intake on stabilization of serum lithium concentration in bipolar disorder: A randomized controlled trial. Bipolar Disord 2023;25(1):66-75. PubMed
- Zhou TL, Schütten MTJ, Kroon AA, et al. Urinary Sodium Excretion and Salt Intake Are Not Associated With Blood Pressure Variability in a White General Population. J Am Heart Assoc 2023;12(1):e026578. PubMed
Histidine 3 references
Methionine 12 references
- La Vecchia C, Negri E, Franceschi S, Decarli A. Case-control study on influence of methionine, nitrite, and salt on gastric carcinogenesis in northern Italy. Nutr Cancer 1997;27:65-8. PubMed
- Btaiche IF, Khalidi N. Parenteral nutrition-associated liver complications in children. Pharmacotherapy 2002;22:188-211.. PubMed
- Cottington EM, LaMantia C, Stabler SP, et al. Adverse event associated with methionine loading test: a case report. Arterioscler Thromb Vasc Biol 2002;22:1046-50.. PubMed
- Anon. Should methionine be added to paracetamol formulations? Drug Ther Perspect 1997;10:11-3. DOI
- Smulders, Y. M., Rakic, M., Slaats, E. H., Treskes, M., Sijbrands, E. J., Odekerken, D. A., Stehouwer, C. D., and Silberbusch, J. Fasting and post-methionine homocysteine levels in NIDDM. Determinants and correlations with retinopathy, albuminuria, and c
- McAuley, D. F., Hanratty, C. G., McGurk, C., Nugent, A. G., and Johnston, G. D. Effect of methionine supplementation on endothelial function, plasma homocysteine, and lipid peroxidation. J.Toxicol.Clin.Toxicol. 1999;37(4):435-440. PubMed
- Hanratty, C. G., McGrath, L. T., McAuley, D. F., Young, I. S., and Johnston, G. D. The effects of oral methionine and homocysteine on endothelial function. Heart 2001;85(3):326-330. PubMed
- Ward, M., McNulty, H., McPartlin, J., Strain, J. J., Weir, D. G., and Scott, J. M. Effect of supplemental methionine on plasma homocysteine concentrations in healthy men: a preliminary study. Int.J.Vitam.Nutr.Res. 2001;71(1):82-86. PubMed
- Yaghmai, R., Kashani, A. H., Geraghty, M. T., Okoh, J., Pomper, M., Tangerman, A., Wagner, C., Stabler, S. P., Allen, R. H., Mudd, S. H., and Braverman, N. Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient
- Talukdar R, Murthy HV, Reddy DN. Role of methionine containing antioxidant combination in the management of pain in chronic pancreatitis: a systematic review and meta-analysis. Pancreatology 2015;15(2):136-44. PubMed
- Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids. Washington, DC: The National Academies Press, 2005. Available at: https://doi.org/10.17226 DOI
- Khairan P, Sobue T, Eshak ES, et al. Association of B Vitamins and Methionine Intake with the Risk of Gastric Cancer: The Japan Public Health Center-based Prospective Study. Cancer Prev Res (Phila) 2022;15(2):101-110. PubMed
Phenylalanine 23 references
- Rouse B, Azen C, Koch R, et al. Maternal phenylketonuria collaborative Study (MPKUCS) offspring: facial anomalies, malformations, and early neurological sequelae. Am J Med Genet 1997;69:89-95. DOI
- Sturtevant FM. Use of aspartame in pregnancy. Int J Fertil 1985;30:85-7.
- Silkaitis RP, Mosnaim AD. Pathways linking L-phenylalanine and 2-phenylethylamine with p-tyramine in rabbit brain. Brain Res 1976;114:105-15.
- Lehmann WD, Theobald N, Fischer R, Heinrich HC. Stereospecificity of phenylalanine plasma kinetics and hydroxylation in man following oral application of a stable isotope-labelled pseudo-racemic mixture of L- and D-phenylalanine. Clin Chim Acta 1983;128 PubMed
- Mosnik DM, Spring B, Rogers K, Baruah S. Tardive dyskinesia exacerbated after ingestion of phenylalanine by schizophrenic patients. Neuropsychopharmacology 1997;16:136-46. PubMed
- Siddiqui AH, Stolk LM, Bhaggoe R, et al. L-phenylalanine and UVA irradiation in the treatment of vitiligo. Dermatology 1994;88:215-8. PubMed
- Birkmayer W, Riederer P, Linauer W, Knoll J. L-deprenyl plus L-phenylalanine in the treatment of depression. J Neural Transm 1984;59:81-7. PubMed
- Nutt JG, Woodward WR, Hammerstad JP, et al. The "on-off" phenomenon in Parkinson's disease. Relation to levodopa absorption and transport. N Engl J Med 1984;310:483-8. PubMed
- Baruzzi A, Contin M, Riva R, et al. Influence of meal ingestion time on pharmacokinetics of orally administered levodopa in parkinsonian patients. Clin Neuropharmacol 1987;10:527-37. PubMed
- Juncos JL, Fabbrini G, Mouradian MM, et al. Dietary influences on the antiparkinsonian response to levodopa. Arch Neurol 1987;44:1003-5. PubMed
- Eriksson T, Granerus AK, Linde A, et al. "On-off" phenomenon in Parkinson's disease: relationship between dopa and other large neutral amino acids in plasma. Neurology 1988;38:1245-8. PubMed
- Baker GB, Bornstein RA, Rouget AC, et al. Phenylethylaminergic mechanisms in attention-deficit disorder. Biol Psychiatry 1991;29:15-22.. PubMed
- Wood DR, Reimherr FW, Wender PH. Treatment of attention deficit disorder with DL-phenylalanine. Psychiatry Res 1985;16:21-6.. PubMed
- Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Energy, Carbohydrate, Fiber, Fat, Fatty Acids, Cholesterol, Protein, and Amino Acids (Macronutrients). Washington, DC: National Academy Press, 2002. Available at: http://www.n
- Cederbaum S. Phenylketonuria: an update. Curr Opin Pediatr 2002;14:702-6. PubMed
- Cejudo-Ferragud, E., Nacher, A., Polache, A., Cercos-Fortea, T., Merino, M., and Casabo, V. G. Evidence of competitive inhibition for the intestinal absorption of baclofen by phenylalanine. Int J of Pharm (Amsterdam) 1996;132:63-69. DOI
- Fischer, E., Heller, B., Nachon, M., and Spatz, H. Therapy of depression by phenylalanine. Preliminary note. Arzneimittelforschung. 1975;25(1):132.
- Beckmann, H., Strauss, M. A., and Ludolph, E. Dl-phenylalanine in depressed patients: an open study. J.Neural Transm. 1977;41(2-3):123-134. PubMed
- Sabelli, H. C., Fawcett, J., Gusovsky, F., Javaid, J. I., Wynn, P., Edwards, J., Jeffriess, H., and Kravitz, H. Clinical studies on the phenylethylamine hypothesis of affective disorder: urine and blood phenylacetic acid and phenylalanine dietary supplem
- Cotzias, G. C., Van Woert, M. H., and Schiffer, L. M. Aromatic amino acids and modification of parkinsonism. N Engl.J Med 2-16-1967;276(7):374-379. PubMed
- Kravitz, H. M., Sabelli, H. C., and Fawcett, J. Dietary supplements of phenylalanine and other amino acid precursors of brain neuroamines in the treatment of depressive disorders. J Am Osteopath.Assoc 1984;84(1 Suppl):119-123. DOI
- Mann, J., Peselow, E. D., Snyderman, S., and Gershon, S. D-phenylalanine in endogenous depression. Am.J.Psychiatry 1980;137(12):1611-1612. PubMed
- Katoulis AC, Alevizou A, Bozi E, et al. A randomized, double-blind, vehicle-controlled study of a preparation containing undecylenoyl phenylalanine 2% in the treatment of solar lentigines. Clin Exp Dermatol 2010;35(5):473-6. PubMed
Threonine 4 references
- Tandan R, Bromberg MB, Forshew D, et al. A controlled trial of amino acid therapy in amyotrophic lateral sclerosis: I. Clinical, functional, and maximum isometric torque data. Neurology 1996;47:1220-6. PubMed
- Lee A, Patterson V. A double blind study of L-threonine in patients with spinal spasticity. Acta Neurol Scand 1993;88:334-8. PubMed
- Blin O, Pouget J, Aubrespy G, et al. A double-blind placebo controlled trial of L-threonine in amyotrophic lateral sclerosis. J Neurol 1992;239:79-81.
- Roufs JB. L-threonine as a symptomatic treatment for amyotrophic lateral sclerosis (ALS). Med Hypotheses 1991;34:20-3. PubMed
L-tryptophan 18 references
- Messiha FS. Fluoxetine: adverse effects and drug-drug interactions. J Toxicol Clin Toxicol 1993;31:603-30. PubMed
- Devoe LD, Castillo RA, Searle NS. Maternal dietary substrates and human fetal biophysical activity. The effects of tryptophan and glucose on fetal breathing movements. Am J Obstet Gynecol 1986;155:135-9. DOI
- Lieberman HR, Corkin S, Spring BJ. The effects of dietary neurotransmitter precursors on human behavior. Am J Clin Nutr 1985;42:366-70. PubMed
- U. S. Food and Drug Administration, Center for Food Safety and Applied Nutrition, Office of Nutritional Products, Labeling, and Dietary Supplements. Information Paper on L-Tryptophan and 5-hydroxy-L-tryptophan, February 2001.
- Sullivan EA, Kamb ML, Jones JL, et al. The natural history of eosinophilia-myalgia syndrome in a tryptophan-exposed cohort in South Carolina. Arch Intern Med 1996;156:973-9. DOI
- Philen RM, Hill RH, Flanders WD, et al. Tryptophan contaminants associated with eosinophilia-myalgia syndrome. Am J Epidemiol 1993;138:154-9. PubMed
- Bohme A, Wolter M, Hoelzer D. L-tryptophan-related eosinophilia-myalgia syndrome possibly associated with a chronic B-lymphocytic leukemia. Ann Hematol 1998;77:235-8. PubMed
- Singhal AB, Caviness VS, Begleiter AF, et al. Cerebral vasoconstriction and stroke after use of serotonergic drugs. Neurology 2002;58:130-3. PubMed
- Priori R, Conti F, Luan FL, et al. Chronic fatigue: a peculiar evolution of eosinophilia myalgia syndrome following treatment with L-tryptophan in four Italian adolescents. Eur J Pediatr 1994;153:344-6..
- Klein R, Berg PA. A comparative study on antibodies to nucleoli and 5-hydroxytryptamine in patients with fibromyalgia syndrome and tryptophan-induced eosinophilia-myalgia syndrome. Clin Investig 1994;72:541-9.. PubMed
- Simat TJ, Kleeberg KK, Muller B, Sierts A. Synthesis, formation, and occurrence of contaminants in biotechnologically manufactured L-tryptophan. Adv Exp Med Biol 1999;467:469-80.. PubMed
- Shaw K, Turner J, Del Mar C. Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database Syst Rev 2002;(1):CD003198. PubMed
- Kilbourne EM, Philen RM, Kamb ML, Falk H. Tryptophan produced by Showa Denko and epidemic eosinophilia-myalgia syndrome. J Rheumatol Suppl 1996;46:81-8.
- Horwitz RI, Daniels SR. Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndrome. J Rheumatol Suppl 1996;46:60-72.
- Shapiro S. Epidemiologic studies of the association of L-tryptophan with the eosinophilia-myalgia syndrome: a critique. J Rheumatol Suppl 1996;46:44-58.
- Mayeno AN, Gleich GJ. The eosinophilia-myalgia syndrome: lessons from Germany. Mayo Clin Proc 1994;69:702-4. PubMed
- Carr L, Ruther E, Berg PA, Lehnert H. Eosinophilia-myalgia syndrome in Germany: an epidemiologic review. Mayo Clin Proc 1994;69:620-5. PubMed
- Ullrich SS, Fitzgerald PCE, Giesbertz P, Steinert RE, Horowitz M, Feinle-Bisset C. Effects of intragastric administration of tryptophan on the blood glucose response to a nutrient drink and energy intake, in lean and obese men. Nutrients 2018;10(4). pii: PubMed
Lysine 7 references
- Thein DJ, Hurt WC. Lysine as a prophylactic agent in the treatment of recurrent herpes simplex labialis. Oral Surg Oral Med Oral Pathol 1984;58:659-66. PubMed
- McCune MA, Perry HO, Muller SA, O'Fallon WM. Treatment of recurrent herpes simplex infections with L-lysine monohydrochloride. Cutis 1984;34:366-73.
- DiGiovanna JJ, Blank H. Failure of lysine in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Arch Dermatol 1984;120:48-51. DOI
- Milman N, Scheibel J, Jessen O. Lysine prophylaxis in recurrent herpes simplex labialis: a double-blind, controlled crossover study. Acta Derm Venereol 1980;60:85-7.
- Griffith RS, Walsh DE, Myrmel KH, et al. Success of L-lysine therapy in frequently recurrent herpes simplex infection. Treatment and prophylaxis. Dermatologica 1987;175:183-90. DOI
- Lo JC, Chertow GM, Rennke H, Seifter JL. Fanconi's syndrome and tubulointerstitial nephritis in association with L-lysine ingestion. Am J Kidney Dis 1996;28:614-7. PubMed
- Smriga M, Torii K. L-Lysine acts like a partial serotonin receptor 4 antagonist and inhibits serotonin-mediated intestinal pathologies and anxiety in rats. Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15370-5.
Parts of this content are provided by the Therapeutic Research Center, LLC.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC